Akari Therapeutics plc ADR (0.01 USD) AKTX

$7.00 -2.51% at last close

Analyst Consensus

Consensus Rating
Buy (3 Buy · 0 Hold · 0 Sell)
Average Price Target
$32.33
Implied Upside
+361.9%
Price Target Range
$27.00 – $40.00
Analysts (12 mo)
3

Recent Analyst Actions

DateFirmActionRatingPrice Target
2026-07-20
Maxim GroupJason McCarthy
 Upgrades Hold → Buy $30
2026-04-08
Maxim GroupJason McCarthy
 Downgrades Buy → Hold —
2026-04-01
HC Wainwright & Co.Sean Lee
 Maintains Buy $2 → $27
2026-01-05
Ladenburg ThalmannAydin Huseynov
 Initiates coverage on Buy $40
2025-09-09
HC Wainwright & Co.Sean Lee
 Reiterates Buy $2
2025-07-18
Maxim GroupJason McCarthy
 Initiates coverage on Buy $5
2022-12-05
HC Wainwright & Co.Sean Lee
 Initiates coverage on Buy $30
2022-11-01
Alliance Global PartnersJames Molloy
 Initiates coverage on Buy $80
2020-03-13
B. Riley SecuritiesMadhu Kumar
 Maintains Buy $140 → $100
2018-03-29
Canaccord GenuityArlinda Lee
 Maintains Buy $300 → $160
2018-02-08
B. Riley SecuritiesMadhu Kumar
 Initiates coverage on Neutral $60
2017-09-22
William BlairTim Lugo
 Upgrades Market perform → Outperform —
2017-05-31
Chardan CapitalMadhu Kumar
 Upgrades Sell → Neutral —
2017-05-12
William BlairTim Lugo
 Downgrades Outperform → Market perform —
2017-04-17
Chardan CapitalMadhu Kumar
 Reiterates Sell $100 → $130
2016-07-11
Chardan CapitalMadhu Kumar
 Initiates coverage on Sell $100

Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.

Key Stats

Last Close
$7.00
Market Cap
$12.57 million
52-Week Range
$3.02 – $49.60
Average Volume
47K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.